PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Clinica Chimica Acta0 citations

Non-coding RNAs as emerging biomarkers in melanoma

View Full Paper
QAQamar AbuhassanMAMutaz Jamal Al-khreisatRRR. Roopashree

Key Points

  • Non-coding RNAs act as emerging biomarkers in melanoma, enhancing diagnosis and prognosis.
  • Significant correlations were identified between non-coding RNA levels and tumor progression in melanoma patients.
  • Observational analysis across multiple melanoma cases highlighted key non-coding RNAs linked to disease outcomes.
  • This work suggests possible diagnostic advancements, although further validation in larger cohorts is necessary.
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Abuhassan et al. (2026) studied this question.

synapsesocial.com/papers/69a76575badf0bb9e87d92bfhttps://doi.org/10.1016/j.cca.2026.120879
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Preoperative Plasma miRNA Levels Predict Prognosis in Early-stage Malignant Melanoma2023 · 8 citations
  2. 2Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty2022 · 180 citations
  3. 3Long non‐coding RNAs in melanoma2018 · 99 citations
  4. 4State of the art in melanoma brain metastatic treatment and evidence of combined high-dose radiotherapy and immunotherapy approach2024 · 4 citations
  5. 5Going circular: history, present, and future of circRNAs in cancer2023 · 246 citations